Skinny Label and Induced Infringement: The Saga Continues
The FDA Law Blog
MAY 11, 2023
government in the now-infamous (at least in FDA circles) Teva v. GSK skinny label case , the U.S. The Government’s concern goes far beyond this case: Like many generic drug sponsors, the Government raises concerns of the implications of the outcome of this case on the skinny label pathway itself.
Let's personalize your content